D.A. DAVIDSON & CO. Q3 2023 Filing

Filed November 8, 2023

Portfolio Value

$9.2B

Holdings

1,314

Report Date

Q3 2023

Filing Type

13F-HR

All Holdings (1,314 positions)

#StockSharesValue% PortfolioType
1301
HRTXHERON THERAPEUTICS INC
40,600$41.0M0.45%
1302
ATYRATYR PHARMA INC
22,750$35.0M0.38%
1303
SACHSACHEM CAP CORP
10,130$35.0M0.38%
1304
RYAMRAYONIER ADVANCED MATLS INC
10,067$35.0M0.38%
1305
LYGLLOYDS BANKING GROUP PLC
15,501$33.0M0.36%
1306
FEAM5E ADVANCED MATERIALS INC
14,292$32.0M0.35%
1307
RGTIWRIGETTI COMPUTING INC
125,000$31.0M0.34%
1308
SLDPSOLID POWER INC
14,300$28.0M0.30%
1309
ABRDN ASIA PACIFIC INCOME FU
10,234$25.0M0.27%
1310
PSEC 6.375 03/01/25PROSPECT CAP CORP
20,000$19.0M0.21%
1311
CHECKPOINT THERAPEUTICS INC
10,000$17.0M0.18%
1312
WDC 1.5 02/01/24WESTERN DIGITAL CORP.
15,000$14.0M0.15%
1313
ONSGBPOUTLOOK THERAPEUTICS INC
28,000$6.0M0.07%
1314
CSSEQCHICKEN SOUP FOR THE SOUL EN
17,042$5.0M0.05%
PreviousPage 14 of 14